The strategic partnership sees two separate financial deals for the pair of oncology assets. Rights to Kelun’s integrin ...

Acute myeloid leukemia (AML) is an aggressive cancer of the blood and bone marrow, characterized by rapid growth of abnormal white blood cells. As AML primarily affects older adults, the global rise ...

Just 10 years ago, there was virtually no biopharmaceutical industry in China. But now, almost all global big pharma ...

China’s growing capabilities have drawn pharmaceutical multinationals to the country to either buy or co-develop innovative ...

With big moves and investments being made via pharma outsourcing, it’s important for industry professionals to stay on top of trends and innovations.

CSPC Pharmaceutical Group Ltd. has obtained approval from China’s National Medical Products Administration (NMPA) to initiate clinical trials with the company’s selective 5-HT2A receptor agonist, ...

The upcoming Gaithersburg facility will join AstraZeneca's local operations, including this cell manufacturing facility in Rockville, which opened in May. Photo credit: Courtesy of AstraZeneca Global ...

Frederick, MD — Gov. Wes Moore on Friday announced that AstraZeneca will invest $2 billion to expand its operations in Maryland in what he described as the “single largest private investment in ...

DEVELOPMENTS FROM FREDERICK. THE INVESTMENT PROVIDES AN ECONOMIC SHOT IN THE ARM, CREATES JOBS AND BOOSTS THE STATE’S EFFORT TO EXPAND MARYLAND’S LIFE SCIENCES SECTOR. TODAY IS ABOUT SHOWING THAT WE ...

Investment supports 2,600 jobs, including 300 highly skilled positions AstraZeneca's expansion aligns with Trump's domestic manufacturing push Announcement is part of drugmaker's $50 billion ...

The pharmaceutical giant is plowing billions of dollars into expanding its drug-making capacity. It has ambitious plans for two facilities in Maryland. AstraZeneca announced it is investing $2 billion ...